N-[2-[4-[2-[4-(2-amino-2-oxoethyl)-1,4-diazoniabicyclo[2.2.2]octan-1-yl]ethyl]anilino]-2-oxoethyl]-4-[methyl-[(2E)-1,3,3-trimethyl-2-[(2E,4E,6E)-7-(1,3,3-trimethylindol-1-ium-2-yl)hepta-2,4,6-trienylidene]indol-5-yl]sulfonylamino]butanamide triacetate

C58H78N8O11S — CID 71766988

IUPACN-[2-[4-[2-[4-(2-amino-2-oxoethyl)-1,4-diazoniabicyclo[2.2.2]octan-1-yl]ethyl]anilino]-2-oxoethyl]-4-[methyl-[(2E)-1,3,3-trimethyl-2-[(2E,4E,6E)-7-(1,3,3-trimethylindol-1-ium-2-yl)hepta-2,4,6-trienylidene]indol-5-yl]sulfonylamino]butanamide triacetate
SMILESCC(=O)[O-].CC(=O)[O-].CC(=O)[O-].CN1/C(=C/C=C/C=C/C=C/C2=[N+](C)c3ccccc3C2(C)C)C(C)(C)c2cc(S(=O)(=O)N(C)CCCC(=O)NCC(=O)Nc3ccc(CC[N+]45CC[N+](CC(N)=O)(CC4)CC5)cc3)ccc21
InChIInChI=1S/C52H66N8O5S.3C2H4O2/c1-51(2)42-16-13-14-17-44(42)57(6)46(51)18-11-9-8-10-12-19-47-52(3,4)43-36-41(25-26-45(43)58(47)7)66(64,65)56(5)28-15-20-49(62)54-37-50(63)55-40-23-21-39(22-24-40)27-29-59-30-33-60(34-31-59,35-32-59)38-48(53)61;3*1-2(3)4/h8-14,16-19,21-26,36H,15,20,27-35,37-38H2,1-7H3,(H-3,53,54,55,61,62,63);3*1H3,(H,3,4)
InChIKeyLFHFFPDZTCCLTH-UHFFFAOYSA-N
MW1095.37 g/mol
LogP1.79
Rot. Bonds18

About N-[2-[4-[2-[4-(2-amino-2-oxoethyl)-1,4-diazoniabicyclo[2.2.2]octan-1-yl]ethyl]anilino]-2-oxoethyl]-4-[methyl-[(2E)-1,3,3-trimethyl-2-[(2E,4E,6E)-7-(1,3,3-trimethylindol-1-ium-2-yl)hepta-2,4,6-trienylidene]indol-5-yl]sulfonylamino]butanamide triacetate

N-[2-[4-[2-[4-(2-amino-2-oxoethyl)-1,4-diazoniabicyclo[2.2.2]octan-1-yl]ethyl]anilino]-2-oxoethyl]-4-[methyl-[(2E)-1,3,3-trimethyl-2-[(2E,4E,6E)-7-(1,3,3-trimethylindol-1-ium-2-yl)hepta-2,4,6-trienylidene]indol-5-yl]sulfonylamino]butanamide triacetate (PubChem CID 71766988) has the molecular formula C58H78N8O11S and a molecular weight of 1095.37 g/mol. Its IUPAC name is N-[2-[4-[2-[4-(2-amino-2-oxoethyl)-1,4-diazoniabicyclo[2.2.2]octan-1-yl]ethyl]anilino]-2-oxoethyl]-4-[methyl-[(2E)-1,3,3-trimethyl-2-[(2E,4E,6E)-7-(1,3,3-trimethylindol-1-ium-2-yl)hepta-2,4,6-trienylidene]indol-5-yl]sulfonylamino]butanamide triacetate.

Molecular Properties

Compound NameN-[2-[4-[2-[4-(2-amino-2-oxoethyl)-1,4-diazoniabicyclo[2.2.2]octan-1-yl]ethyl]anilino]-2-oxoethyl]-4-[methyl-[(2E)-1,3,3-trimethyl-2-[(2E,4E,6E)-7-(1,3,3-trimethylindol-1-ium-2-yl)hepta-2,4,6-trienylidene]indol-5-yl]sulfonylamino]butanamide triacetate
PubChem CID71766988
Molecular FormulaC58H78N8O11S
Molecular Weight1095.37 g/mol
Exact Mass1094.55
IUPAC NameN-[2-[4-[2-[4-(2-amino-2-oxoethyl)-1,4-diazoniabicyclo[2.2.2]octan-1-yl]ethyl]anilino]-2-oxoethyl]-4-[methyl-[(2E)-1,3,3-trimethyl-2-[(2E,4E,6E)-7-(1,3,3-trimethylindol-1-ium-2-yl)hepta-2,4,6-trienylidene]indol-5-yl]sulfonylamino]butanamide triacetate
SMILESCC(=O)[O-].CC(=O)[O-].CC(=O)[O-].CN1/C(=C/C=C/C=C/C=C/C2=[N+](C)c3ccccc3C2(C)C)C(C)(C)c2cc(S(=O)(=O)N(C)CCCC(=O)NCC(=O)Nc3ccc(CC[N+]45CC[N+](CC(N)=O)(CC4)CC5)cc3)ccc21
InChIInChI=1S/C52H66N8O5S.3C2H4O2/c1-51(2)42-16-13-14-17-44(42)57(6)46(51)18-11-9-8-10-12-19-47-52(3,4)43-36-41(25-26-45(43)58(47)7)66(64,65)56(5)28-15-20-49(62)54-37-50(63)55-40-23-21-39(22-24-40)27-29-59-30-33-60(34-31-59,35-32-59)38-48(53)61;3*1-2(3)4/h8-14,16-19,21-26,36H,15,20,27-35,37-38H2,1-7H3,(H-3,53,54,55,61,62,63);3*1H3,(H,3,4)
InChIKeyLFHFFPDZTCCLTH-UHFFFAOYSA-N
XLogP1.79
TPSA265.31 Ų
H-Bond Donors3
H-Bond Acceptors12
Rotatable Bonds18
Heavy Atoms78
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 5001095.37
LogP ≤ 51.79
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 1012

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'polyene', 'substructure': 'N/A'}, {'alert_name': 'quaternary_nitrogen_1', 'substructure': 'N/A'}, {'alert_name': 'quaternary_nitrogen_2', 'substructure': 'N/A'}

Analyze N-[2-[4-[2-[4-(2-amino-2-oxoethyl)-1,4-diazoniabicyclo[2.2.2]octan-1-yl]ethyl]anilino]-2-oxoethyl]-4-[methyl-[(2E)-1,3,3-trimethyl-2-[(2E,4E,6E)-7-(1,3,3-trimethylindol-1-ium-2-yl)hepta-2,4,6-trienylidene]indol-5-yl]sulfonylamino]butanamide triacetate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[2-[4-[2-[4-(2-amino-2-oxoethyl)-1,4-diazoniabicyclo[2.2.2]octan-1-yl]ethyl]anilino]-2-oxoethyl]-4-[methyl-[(2E)-1,3,3-trimethyl-2-[(2E,4E,6E)-7-(1,3,3-trimethylindol-1-ium-2-yl)hepta-2,4,6-trienylidene]indol-5-yl]sulfonylamino]butanamide triacetate?
The IUPAC name of N-[2-[4-[2-[4-(2-amino-2-oxoethyl)-1,4-diazoniabicyclo[2.2.2]octan-1-yl]ethyl]anilino]-2-oxoethyl]-4-[methyl-[(2E)-1,3,3-trimethyl-2-[(2E,4E,6E)-7-(1,3,3-trimethylindol-1-ium-2-yl)hepta-2,4,6-trienylidene]indol-5-yl]sulfonylamino]butanamide triacetate (CID 71766988) is N-[2-[4-[2-[4-(2-amino-2-oxoethyl)-1,4-diazoniabicyclo[2.2.2]octan-1-yl]ethyl]anilino]-2-oxoethyl]-4-[methyl-[(2E)-1,3,3-trimethyl-2-[(2E,4E,6E)-7-(1,3,3-trimethylindol-1-ium-2-yl)hepta-2,4,6-trienylidene]indol-5-yl]sulfonylamino]butanamide triacetate.
What is the SMILES notation for N-[2-[4-[2-[4-(2-amino-2-oxoethyl)-1,4-diazoniabicyclo[2.2.2]octan-1-yl]ethyl]anilino]-2-oxoethyl]-4-[methyl-[(2E)-1,3,3-trimethyl-2-[(2E,4E,6E)-7-(1,3,3-trimethylindol-1-ium-2-yl)hepta-2,4,6-trienylidene]indol-5-yl]sulfonylamino]butanamide triacetate?
The canonical SMILES for N-[2-[4-[2-[4-(2-amino-2-oxoethyl)-1,4-diazoniabicyclo[2.2.2]octan-1-yl]ethyl]anilino]-2-oxoethyl]-4-[methyl-[(2E)-1,3,3-trimethyl-2-[(2E,4E,6E)-7-(1,3,3-trimethylindol-1-ium-2-yl)hepta-2,4,6-trienylidene]indol-5-yl]sulfonylamino]butanamide triacetate is CC(=O)[O-].CC(=O)[O-].CC(=O)[O-].CN1/C(=C/C=C/C=C/C=C/C2=[N+](C)c3ccccc3C2(C)C)C(C)(C)c2cc(S(=O)(=O)N(C)CCCC(=O)NCC(=O)Nc3ccc(CC[N+]45CC[N+](CC(N)=O)(CC4)CC5)cc3)ccc21.
What is the InChIKey of N-[2-[4-[2-[4-(2-amino-2-oxoethyl)-1,4-diazoniabicyclo[2.2.2]octan-1-yl]ethyl]anilino]-2-oxoethyl]-4-[methyl-[(2E)-1,3,3-trimethyl-2-[(2E,4E,6E)-7-(1,3,3-trimethylindol-1-ium-2-yl)hepta-2,4,6-trienylidene]indol-5-yl]sulfonylamino]butanamide triacetate?
The InChIKey is LFHFFPDZTCCLTH-UHFFFAOYSA-N. The full InChI is InChI=1S/C52H66N8O5S.3C2H4O2/c1-51(2)42-16-13-14-17-44(42)57(6)46(51)18-11-9-8-10-12-19-47-52(3,4)43-36-41(25-26-45(43)58(47)7)66(64,65)56(5)28-15-20-49(62)54-37-50(63)55-40-23-21-39(22-24-40)27-29-59-30-33-60(34-31-59,35-32-59)38-48(53)61;3*1-2(3)4/h8-14,16-19,21-26,36H,15,20,27-35,37-38H2,1-7H3,(H-3,53,54,55,61,62,63);3*1H3,(H,3,4).
What are the key properties of N-[2-[4-[2-[4-(2-amino-2-oxoethyl)-1,4-diazoniabicyclo[2.2.2]octan-1-yl]ethyl]anilino]-2-oxoethyl]-4-[methyl-[(2E)-1,3,3-trimethyl-2-[(2E,4E,6E)-7-(1,3,3-trimethylindol-1-ium-2-yl)hepta-2,4,6-trienylidene]indol-5-yl]sulfonylamino]butanamide triacetate?
N-[2-[4-[2-[4-(2-amino-2-oxoethyl)-1,4-diazoniabicyclo[2.2.2]octan-1-yl]ethyl]anilino]-2-oxoethyl]-4-[methyl-[(2E)-1,3,3-trimethyl-2-[(2E,4E,6E)-7-(1,3,3-trimethylindol-1-ium-2-yl)hepta-2,4,6-trienylidene]indol-5-yl]sulfonylamino]butanamide triacetate has a molecular weight of 1095.37 g/mol, XLogP of 1.79, 18 rotatable bonds, 3 hydrogen bond donors, and 12 hydrogen bond acceptors.
Where does this data come from?
All data for N-[2-[4-[2-[4-(2-amino-2-oxoethyl)-1,4-diazoniabicyclo[2.2.2]octan-1-yl]ethyl]anilino]-2-oxoethyl]-4-[methyl-[(2E)-1,3,3-trimethyl-2-[(2E,4E,6E)-7-(1,3,3-trimethylindol-1-ium-2-yl)hepta-2,4,6-trienylidene]indol-5-yl]sulfonylamino]butanamide triacetate is sourced from PubChem (CID 71766988), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).